MeSH Browser

MeSH Supplementary: AML8A protocol
Unique ID: C081693
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/C081693
Registry Numbers: 0
Heading Mapped to: Amsacrine; *Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin
Frequency: 2
Note: chemotherapy regimen consisting of above cpds and bone marrow transplant; used in the therapy of myeloblastic acute leukemia
Source: Nouv Rev Fr Hematol 1993 Feb;35(1):15-6
Date of Entry: 1993/07/13
Revision Date: 2000/11/30

AML8A protocol MeSH Supplementary Concept Data 2025